With increasing survival after orthotopic liver transplantation (OLT), metabolic syndrome and
its individual components, including diabetes mellitus, hypertension, dyslipidemia, and …

GUIDELINE DEVELOPMENT Non-alcoholic steatohepatitis (NASH) is an increasing cause
of liver disease necessitating liver transplantation. In patients with advanced NASH, there …

Cirrhosis secondary to non-alcoholic steatohepatitis (NASH) is a common indication for liver
transplant. In comparison to other cirrhotic patients, patients with NASH cirrhosis are more …

Cardiovascular disease and its concurrent risk factors are prevalent after liver transplant
(LT). Most of these risk factors are modifiable by diet. We aimed to synthesise the literature …

Background: Cirrhosis is the end stage of many different forms of acute and chronic liver
damages. Interactions between liver and endocrine system is significant, because liver is the …

Metabolic syndrome is defined as the mutual existence of obesity, impaired fasting glucose
levels, insulin resistance, hypertension, and dyslipidemia. After liver transplantation, patients …

Liver transplantation (LT) is considered the curative treatment option for selected patients
who suffer from end-stage or acute liver disease or hepatic malignancy (primary). After LT …

Liver transplantation is a life‐saving therapy for patients with end‐stage liver disease, acute
liver failure, and liver tumors. Over the past 4 decades, improvements in surgical techniques …

Our data about pathogenesis of hepatic steatosis after liver transplantation is scarce. This
study aimed to investigate the association between serum adipokines and insulin resistance …

Abstract Objectives: Nonalcoholic steatohepatitis (NASH), which is a common and
increasing indication for liver transplantation (LT), is known to recur after LT. Since the …